TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
BHVN

Biohaven Ltd.

Healthcare · Biotechnology

13.00$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Biohaven Ltd. (BHVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -85 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BHVN
Line item Q1 17 Q1 18 Q4 18 Q1 19 Q4 19 Q1 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-7.7 -82 -108 -47 -249 -151 -505 -206 -35 -44 -33 -59 -68 -96 -75 -78 -44 -95 -115 -103 -168 -141 -171 -165 -168 -146 -131 -150 -85 -511
0.0 0.0 0.0 – 0.0 – 9.4 5.1 0.2 0.2 0.7 0.3 0.4 0.4 0.3 1.6 1.8 1.5 1.9 1.4 2.0 2.0 2.5 2.2 2.0 3.1 2.6 2.4 2.3 10
1.9 3.1 12 7.3 45 17 33 49 19 15 13 40 21 17 116 3.8 4.7 4.5 16 35 12 12 13 53 21 22 17 28 19 86
– – – – – – – – – 19 23 78 78 17 126 3.4 3.4 3.4 – – – – – – – – – – – –
2.7 4.2 -6.9 -2.5 -1.7 6.5 -4.0 -18 -0.9 -8.7 6.6 -3.7 20 -44 -1.0 -11 41 2.8 -8.7 26 -23 21 -6.0 -4.4 19 -3.0 -9.8 -53 17 -49
0.0 0.4 3.8 1.0 1.1 1.0 0.3 1.2 0.4 0.0 0.2 0.2 36 4.5 0.3 0.7 0.6 1.2 0.5 0.4 2.9 0.6 0.0 0.5 0.2 0.0 0.0 0.0 0.5 0.5
-1.6 -1.7 -7.2 -1.0 -1.0 -23 -245 120 0.6 0.0 -0.2 -0.2 -36 -4.5 -264 -1.1 76 59 -3.9 34 -98 -93 -88 165 -16 165 -14 15 45 211
– – – – – – – – – – -31 – – – – – – – – – – – 12 – – – 1.8 – – –
– – – – – – – – – – 70 – – – – – – – – – – 0.0 – – – 0.0 0.0 – – –
38 56 247 1.1 378 286 502 421 38 315 -252 23 87 128 530 27 -20 -40 245 3.4 321 80 273 0.4 250 0.1 189 179 3.8 372
29 -27 131 -47 100 112 -295 335 4.0 271 -286 -36 -17 27 191 -52 11 -76 126 -65 55 -154 15 0.1 66 19 44 44 -36 72
-7.7 -82 -112 -48 -250 -152 -506 -207 -35 -44 -33 -59 -104 -100 -76 -78 -45 -96 -115 -103 -171 -142 -171 -166 -168 -146 -131 -150 -86 -512

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?